Loading...
XWAR
MDG
Market cap80mUSD
Jul 11, Last price  
29.60PLN
1D
1.54%
1Q
16.54%
Jan 2017
-90.39%
IPO
40.95%
Name

Medicalgorithmics SA

Chart & Performance

D1W1MN
P/E
P/S
6.84
EPS
Div Yield, %
Shrs. gr., 5y
22.51%
Rev. gr., 5y
-26.39%
Revenues
43m
-31.28%
4,107,3115,804,96610,961,65815,697,40029,714,10049,330,500127,921,000203,354,000199,404,000173,870,000111,734,000120,563,00062,719,00043,098,000
Net income
-578k
L
1,909,9853,005,8727,438,75210,874,10014,526,30013,925,40040,108,00025,539,00014,416,000-299,000-27,676,000-180,638,00018,088,000-578,000
CFO
182k
-97.13%
1,669,3692,688,8184,112,9205,576,900-2,907,70017,347,10035,477,00028,611,00044,232,00013,499,000-3,956,000-6,479,0006,331,000182,000
Dividend
Jul 13, 20181.42 PLN/sh

Profile

Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.
IPO date
Nov 09, 2011
Employees
122
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
43,098
-31.28%
62,719
-47.98%
Cost of revenue
40,443
20,018
Unusual Expense (Income)
NOPBT
2,655
42,701
NOPBT Margin
6.16%
68.08%
Operating Taxes
340
(216)
Tax Rate
12.81%
NOPAT
2,315
42,917
Net income
(578)
-103.20%
18,088
-110.01%
Dividends
Dividend yield
Proceeds from repurchase of equity
13,870
BB yield
-19.84%
Debt
Debt current
9
Long-term debt
1,394
5,513
Deferred revenue
(4,244)
Other long-term liabilities
16,771
8,760
Net debt
(24,107)
(20,663)
Cash flow
Cash from operating activities
182
6,331
CAPEX
(488)
(12,374)
Cash from investing activities
1,963
(1,812)
Cash from financing activities
(2,809)
9,979
FCF
1,463
60,887
Balance
Cash
25,501
26,165
Long term investments
20
Excess cash
23,346
23,049
Stockholders' equity
(118,416)
80,079
Invested Capital
227,753
65,674
ROIC
1.58%
65.46%
ROCE
2.43%
44.01%
EV
Common stock shares outstanding
9,953
5,701
Price
30.55
149.18%
12.26
-35.27%
Market cap
304,064
335.03%
69,894
-18.84%
EV
279,966
49,240
EBITDA
5,021
46,924
EV/EBITDA
55.76
1.05
Interest
105
271
Interest/NOPBT
3.95%
0.63%